184 related articles for article (PubMed ID: 2210166)
1. [Torsade de pointes induced by quinidine: a case treated successfully with verapamil].
Ometto R; Arfiero S; Vincenzi M
G Ital Cardiol; 1990 May; 20(5):431-4. PubMed ID: 2210166
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of isoproterenol, magnesium sulfate and verapamil for torsade de pointes].
Yamamoto H; Bando S; Nishikado A; Hamai K; Yamamoto K; Shinohara A
Kokyu To Junkan; 1991 Mar; 39(3):261-5. PubMed ID: 2047605
[TBL] [Abstract][Full Text] [Related]
3. QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine.
Lin JC; Quasny HA
Pharmacotherapy; 1997; 17(3):626-30. PubMed ID: 9165570
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of isoproterenol on quinidine induced torsade de pointes.
Yamamoto H; Bando S; Nishikado A; Shinohara A; Hamai K; Yamamoto K; Ikefuji H; Ito S
Tokushima J Exp Med; 1991 Jun; 38(1-2):1-4. PubMed ID: 1948996
[TBL] [Abstract][Full Text] [Related]
5. Propafenone-induced torsade de pointes: cross-reactivity with quinidine.
Hii JT; Wyse DG; Gillis AM; Cohen JM; Mitchell LB
Pacing Clin Electrophysiol; 1991 Nov; 14(11 Pt 1):1568-70. PubMed ID: 1721143
[TBL] [Abstract][Full Text] [Related]
6. [Torsade de pointes tachycardia during administration of quinidine and verapamil in atrial fibrillation].
Karch M; Schmitt C; Plewan A; Schmidt G; Schömig A
Herz; 1997 Feb; 22(1):51-6. PubMed ID: 9173039
[TBL] [Abstract][Full Text] [Related]
7. Prolonged quinidine half-life with associated toxicity in a patient with hepatic failure.
Stanek EJ; Simko RJ; DeNofrio D; Pavri BB
Pharmacotherapy; 1997; 17(3):622-5. PubMed ID: 9165569
[TBL] [Abstract][Full Text] [Related]
8. Torsade de pointes with amiodarone in a patient with previous torsade during beta-receptor blockade.
Skanes AC; Morton BC; Green MS; Tang AS
Can J Cardiol; 1997 Apr; 13(4):383-6. PubMed ID: 9141970
[TBL] [Abstract][Full Text] [Related]
9. Drug-induced torsade de pointes.
Raehl CL; Patel AK; LeRoy M
Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
[TBL] [Abstract][Full Text] [Related]
10. Female preponderance in ibutilide-induced torsade de pointes.
Gowda RM; Khan IA; Punukollu G; Vasavada BC; Sacchi TJ; Wilbur SL
Int J Cardiol; 2004 Jun; 95(2-3):219-22. PubMed ID: 15193823
[TBL] [Abstract][Full Text] [Related]
11. [Combination of quinidine and verapamil in auricular fibrillation].
Sobrino JA; Maté I; Calvo L; Plaza I; Rico J; Moreno I; Mesa JM
Rev Esp Cardiol; 1989 Apr; 42(4):262-6. PubMed ID: 2781120
[TBL] [Abstract][Full Text] [Related]
12. Torsade de pointes with sotalol overdose treated successfully with lidocaine.
Assimes TL; Malcolm I
Can J Cardiol; 1998 May; 14(5):753-6. PubMed ID: 9627533
[TBL] [Abstract][Full Text] [Related]
13. [Short coupled variant of torsade de pointes: our experience and review of the literature].
Fehri W; Abdessalem S; Smiri Z; Mhenni H; Barakett N; Rahal N; Haouala H
Tunis Med; 2004 Sep; 82(9):867-74. PubMed ID: 15693481
[TBL] [Abstract][Full Text] [Related]
14. [Long QT syndrome induced by cordaron and quinidine].
Mironchik EV; Dolgosheĭ TS; Liskovich TG; Madeshkina GA; Kokhkovski AB; Tyshchenko AD
Klin Med (Mosk); 2007; 85(3):69-71. PubMed ID: 17523411
[TBL] [Abstract][Full Text] [Related]
15. [Amiodarone therapy after sotalol-induced torsade de pointes: prolonged QT interval and QT dispersion in differentiation of pro-arrhythmic effects].
van de Loo A; Klingenheben T; Hohnloser SH
Z Kardiol; 1994 Dec; 83(12):887-90. PubMed ID: 7846927
[TBL] [Abstract][Full Text] [Related]
16. Moxifloxacin and torsade de pointes.
Dale KM; Lertsburapa K; Kluger J; White CM
Ann Pharmacother; 2007 Feb; 41(2):336-40. PubMed ID: 17284508
[TBL] [Abstract][Full Text] [Related]
17. Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports.
Faber TS; Zehender M; Van de Loo A; Hohnloser S; Just H
Clin Cardiol; 1994 Apr; 17(4):197-202. PubMed ID: 8187370
[TBL] [Abstract][Full Text] [Related]
18. Torsade de pointes induced by short-term oral amiodarone therapy.
Lim HE; Pak HN; Ahn JC; Song WH; Kim YH
Europace; 2006 Dec; 8(12):1051-3. PubMed ID: 17148550
[TBL] [Abstract][Full Text] [Related]
19. Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias.
Shantsila E; Watson T; Lip GY
Europace; 2007 Sep; 9 Suppl 4():iv37-44. PubMed ID: 17766322
[TBL] [Abstract][Full Text] [Related]
20. Ciprofloxacin-induced torsade de pointes.
Flanagan MC; Mitchell ES; Haigney MC
Int J Cardiol; 2006 Nov; 113(2):239-41. PubMed ID: 16386810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
